Skip to contentB
Bio-Rad Laboratories, Inc.
B
BIOBio-Rad Laboratories, Inc. Q1 2014 · 10-Q
Revenue$509.30M$509.30M+1.9% vs Q1 2013 Net Income$6.70M$6.70M−66.8% vs Q1 2013 EPS Diluted$0.23$0.23−67.1% vs Q1 2013 Gross Profit$275,300,000+1.4% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Bio-Rad Laboratories, Inc. · CIK 12208 · Engraved from SEC EDGAR
Operating Cash Flow$65,570,000+173.0% Free Cash Flowderived$42,989,000N/M Margins · derivedGross margin54.1%−0.3 pt vs Q1 2013
Operating margin4.0%−3.0 pt vs Q1 2013
Net margin1.3%−2.7 pt vs Q1 2013
ended Mar 31, 2014 · filed May 8, 2014 · 38 d after period end